Skip to content
★ Sign in to follow
CB

Calypte Biomedical Corp Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by MARR TECHNOLOGIES BV, was filed 10 Oct 2006.

Calypte Biomedical Corp: what insiders have been doing

Insider filings for Calypte Biomedical Corp are scarce in the SEC (Form 4) feed, the latest one published on 24 September 2008. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
17
Thresholds
n/a
Buy Volume
€2M
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 24 September 2008
Declarations17 total
  • ◆
    10% OwnerExecutives
    320,000 USD0SEC
    4,000,000 shares@ US$0.08Common stock, $0.03 par value per shareSEC:0001140361-08-021873:0
  • ◆
    10% OwnerExecutives
    496,000 USD0SEC
    9,920,000 shares@ US$0.05Common stock, $0.03 par value per shareSEC:0001140361-08-021873:1
  • ◆
    10% OwnerExecutives
    110,000 USD0SEC
    1,375,000 shares@ US$0.08Common stock, $0.03 par value per shareSEC:0001140361-08-021515:0
  • ◆
    10% OwnerExecutives
    100,000 USD0SEC
    2,000,000 shares@ US$0.05Common stock, $0.03 par value per shareSEC:0001140361-08-021515:1
  • ◆
    10% OwnerExecutives
    160,000 USD0SEC
    2,000,000 shares@ US$0.08Common stock, $0.03 par value per shareSEC:0001140361-08-021508:0
  • ◆
    10% OwnerExecutives
    100,000 USD0SEC
    2,000,000 shares@ US$0.05Common stock, $0.03 par value per shareSEC:0001140361-08-021508:1
  • ◆
    10% OwnerExecutives
    350,000 USD0SEC
    4,375,000 shares@ US$0.08Common stock, $0.03 par value per shareSEC:0001140361-08-021511:0
  • ◆
    10% OwnerExecutives
    300,000 USD0SEC
    6,000,000 shares@ US$0.05Common stock, $0.03 par value per shareSEC:0001140361-08-021511:1
  • ◆
    President and Chief ExecutiveExecutives
    0SEC
    1,000,000 sharesCommon Stock, par value $0.03SEC:0001144204-08-042844:0
  • ◆
    President and CEOExecutives
    25,894 USD0SEC
    323,669 shares@ US$0.08Common StockSEC:0001144204-08-020471:0
  • ●
    Chairman, President and CEOExecutives
    453,537 USD0SEC
    8,721,870 shares@ US$0.052Common stock, $0.03 par valueSEC:0001144204-07-015850:0
  • ●
    Executive Vice PresidentExecutives
    200,000 USD0SEC
    3,846,154 shares@ US$0.052Common stock, $0.03 par valueSEC:0001144204-07-015840:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    2,000,000 sharesCommon StockSEC:0001144204-07-002750:0
  • ●
    Related company / holdingExecutives
    0SEC
    1,968,750 shares0Common Stock, Anti-dilution AdjustmentSEC:0000882377-06-003447:0
  • ▲
    Related company / holdingExecutives
    3M USD0SEC
    16,964,583 shares@ US$0.15Common StockSEC:0000882377-06-003447:1
    Canonical exit: 19 Oct 2006 (T+90)
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    311,736 shares0Common StockSEC:0001144204-06-005137:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    1,000,000 sharesCommon StockSEC:0001144204-06-000741:0

17 of 17 declarations

About Calypte Biomedical Corp

Calypte Biomedical Corp is a company focused on developing medical technologies, particularly in the field of screening tests. It is listed on the NASDAQ under the symbol XNAS.